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Accepted 30 May 2011AbstractObjective: To present molecular cytogenetic characterization of a prenatally detected duplication of 15q26.2/ q26.3 in a fetus with overgrowth.
Case Report: A 34-year-old para 0 woman underwent amniocentesis at 18 weeks of gestation because of advanced maternal age. Amniocentesis
revealed a derivative chromosome 15, or der(15), with additional material at the end of the long arm of one chromosome 15. Parental karyotypes
were normal. Fetal overgrowth was first noted at 21 weeks of gestation. Repeated amniocentesis was performed at 22 weeks of gestation. Array
comparative genomic hybridization revealed a 4.71-Mb duplication from 15q26.2 to 15q26.3 encompassing the IGF1R gene. Fluorescence in
situ hybridization analysis using the bacterial artificial chromosome clone probes specific for 15q26.2-q26.3 and the subtelomeric region of 15q
showed a direct duplication and no terminal deletion in the der(15). Polymorphic DNA marker analysis determined a paternal origin of the
duplication of 15q. Level II ultrasound at 23 weeks of gestation revealed a fetal biometry equivalent to 26 weeks. The pregnancy was
subsequently terminated, and a 1062-g (>99th centile) malformed fetus was delivered at 24 weeks of gestation with craniofacial dysmorphism,
craniosynostosis, and overgrowth.
Conclusion: The present case provides evidence for prenatal overgrowth, craniosynostosis, and characteristic facial dysmorphism in association
with a duplication of 15q26.2/ q26.3 and a duplication of the IGF1R gene. Prenatal diagnosis of fetal overgrowth should include a differential
diagnosis of the chromosome 15q overgrowth syndrome.
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The chromosome 15q overgrowth syndrome is an over-
growth syndrome caused by increased gene dosage of IGF1R
through duplication or triplication of the 15q26.1-qter region
involving 15q26.3 because of trisomy and tetrasomy of distal
chromosome 15q [1]. This syndrome is characterized by the
clinical features of overgrowth, learning difficulties, a charac-
teristic facial appearance of a long thin face with a prominent
chin and nose, and renal anomalies of renal agenesis, horse-
shoe kidneys, and hydronephrosis [1]. Prenatal diagnosis of
the chromosome 15q overgrowth syndrome is unusual. Here
we report prenatal diagnosis, molecular cytogenetic charac-
terization, and perinatal findings in a fetus with a duplication
of 15q26.2/ q26.3 and overgrowth.
Case report
A 34-year-old, gravid 2, para 0, woman underwent amnio-
centesis at 18 weeks of gestation because of her advanced
maternal age. The woman had experienced two spontaneous
abortions. Her husband was 35 years old. Cytogenetic analysis
then revealed a derivative chromosome 15, or der(15), with
additional material at the end of the long arm of one chromo-
some 15 (Fig. 1). The parental karyotypes were normal. Prenatal
ultrasound examinations had revealed a fetal biometry equiva-
lent to 16 weeks [biparietal diameter (BPD)¼ 2.9 cm (16th
centile), femur length (FL)¼ 2.2 cm (79th centile)] at 16 weeks
of gestation and a fetal biometry equivalent to 23 weeks
[BPD¼ 5.78 cm (>99th centile), FL¼ 3.54 cm (72nd centile)]
at 21 weeks of gestation. Thewoman requested amniocentesis at
22 weeks of gestation. Using uncultured amniocytes, oligonu-
cleotide (oligo)-based array comparative genomic hybridization
(aCGH) (CytoChip Oligo; BlueGnome, Cambridge, UK)
demonstrated a 4.71-Mb duplication from 15q26.2 to 15q26.3
(95,490,272e100,200,967 bp) (NCBI build 36, March 2006)
(Fig. 2). The result of oligo-aCGH was arr cgh 15q26.2q26.3
(95,490,272e100,200,967)3. For fluorescence in situ hybrid-
ization (FISH) determination of the orientation of the duplica-
tion and no terminal deletion in the der(15), the bacterial
artificial chromosome (BAC) clone probes mapping theFig. 1. (A) A karyotype 46,XY,dup(15)(q26.2q26.3) in the fetus. (B) Partial G-b
derivative chromosome 15, or der(15), with dup(15q)(q26.2q26.3). The arrows indgenomic region of 15q26.2-q26.3 and the subtelomeric region
of 15q were used. The BAC clone probes RP11-308P12
(96,148,983e96,341,797) (spectrum green) and RP11-66B24
(99,149,459e99,322,865) (spectrum red) were used to deter-
mine the orientation of the duplication. FISH analysis showed an
orientation of green-[(red-green) or yellow]-red consistent with
the diagnosis of a direct duplication of distal 15q (Fig. 3). The
BAC clone probe RP11-259N2 (100,094,760e100,248,597)
(spectrum green) was used to determine the presence of the
subtelomeric region of the der(15). FISH analysis showed no
terminal deletion in the der(15) (Fig. 4). The karyotype of the
fetus was 46,XY,dup(15) (q26.2q26.3) (Fig. 1). Level II ultra-
sound at 23 weeks of gestation revealed a fetal biometry
equivalent to 26 weeks [BPD¼ 6.7 cm (>99th centile),
abdominal circumference¼ 21.6 cm (>99th centile), and
FL¼ 4.56 cm (>99th centile). The internal organs were unre-
markable. The parents elected to terminate the pregnancy, and
a 1062-g (>99th centile) malformed fetus was delivered at 24
weeks of gestation. The fetus manifested macrocephaly, an
elongated face, a sloping forehead, down-slanting palpebral
fissures, hypertelorism, a down-turned mouth, and a prominent
nose and chin (Fig. 5). Three-dimensional computed tomog-
raphy scans of the skull showed premature synostosis of the
metopic and coronal sutures (Fig. 6). Quantitative fluorescent
polymerase chain reaction analysis using polymorphic DNA
markers determined a paternal origin of the duplication (Fig. 7)
(Table 1).
Discussion
The present case had a direct duplication of
15q26.2/ q26.3 and a duplication of the IGF1R gene, and
manifested prenatal overgrowth, craniosynostosis, and char-
acteristic facial dysmorphism. Insulin-like growth factor 1
receptor [Online Mendelian Inheritance in Man (OMIM)
147370] is the receptor for type 1 insulin-like growth factor
(IGF1) (OMIM 147440). The IGF1R gene is mapped to
15q26.3 and is involved in growth, insulin-related phenotypes,
and longevity. The IGF1R gene is expressed equally from the
maternal and paternal alleles in humans and has not been
known to be imprinted [2,3]. Insulin-like growth factor 1anded karyotype of the fetus showing one normal chromosome 15 and one
icate the breakpoints. dup¼ duplication.
Fig. 2. Oligonucleotide-based array comparative genomic hybridization shows a 4.71-Mb duplication from 15q26.2 to 15q26.3 [arr cgh 15q26.2q26.3
(95,490,272e100,200,967)3] (arrow). arr cgh¼ array comparative genomic hybridization.
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Gene dosage increase of IGF1R can lead to overgrowth,
whereas gene dosage decrease of IGF1R can cause growth
retardation. Okubo et al [4] reported accelerated growth of the
skin fibroblasts in a tall child with three copies of the IGF1R
gene and slower growth of the skin fibroblasts in a short child
with one copy of the IGF1R gene. Faivre et al [5] observed
a specific phenotype of macrosomia at birth, overgrowth,
macrocephaly, and mild developmental delay in patients withtrisomy 15q26.1-qter. Kant et al [6] reported tall stature and
mental retardation in patients with trisomy 15q26-qter and
a duplication of the IGF1R gene. Abuzzahab et al [7] postu-
lated that mutations in the IGF1R gene may result in IGF1
resistance and underline intrauterine growth retardation and
subsequent short stature. Bonafe` et al [8] hypothesized that the
polymorphic variants of IGF1R play a role in systemic IGF1
regulation and human longevity by down-regulating the IGF1
pathway or IGF1 plasma levels.
Fig. 3. Fluorescence in situ hybridization using bacterial artificial chromosome
clone probes RP11-308P12 (96,148,983e96,341,797) (spectrum green) at
15q26.2-q26.3 and RP11-66B24 (99,149,459e99,322,865) (spectrum red) at
15q26.3. A direct duplication of 15q in the orientation of green-[(red-green) or
yellow]-red is evident in the der(15). The inset shows the amplified der(15)
and chromosome 15.
Fig. 4. Fluorescence in situ hybridization using bacterial artificial chromosome
clone probes RP11-259N2 (100,094,760e100,248,597) (spectrum green) at
15q26.3 and RP11-138H15 (19,375,579e19,534,126) (spectrum red) at
15q11.2 as internal control shows presence of the green signal in the der(15).
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patients [1,4,6,9e14]. In case of mixed or non-pure trisomy for
distal 15q, the chromosome aberration has arisen from an
unbalanced reciprocal translocation inherited from the parent
and contains a deletion of another chromosome. The phenotype
of such a case thus can be attributed to monosomy of the
involved chromosome in addition to partial trisomy 15q. The
reported monosomies associated with non-pure trisomy 15q
includemonosomic components of chromosomes 2q [6,15e18],Fig. 5. The craniofacial appea12p [19], 13q [5,20,21], 14p [1], 15p [1], and 20p [5]. Inv dup
del(15q) has been reported in one case [30]. Genesio et al [30]
reported an inverted duplication of 15q and a terminal 15q
deletion in a case with three copies of the IGF1R gene, marked
intrauterine growth restriction, congenital heart defects, horse-
shoe kidneys, hand contractures, and club feet. In case of tet-
rasomy for distal 15q, the tetrasomy is the result of an acentric
inverted duplication of distal 15q in the form of mosaic or non-
mosaic distribution of an analphoid supernumerary marker
chromosome [1,22e29]. To date, about 41 patients with trisomy
or tetrasomy for distal 15q have been reported. Among the 41
reported cases with trisomy or tetrasomy for distal 15q, only six
cases manifested craniosynostosis [15,19e21,25]. Our case
adds to the list of trisomy or tetrasomy for distal 15q with
craniosynostosis.
Prenatal diagnosis of fetal overgrowth should include
a differential diagnosis of incorrect gestational dating; normalrance of the fetus at birth.
Fig. 6. Three-dimensional computed tomography scans of the skull shows
premature synostosis of the metopic and coronal sutures.
Fig. 7. Representative electrophoretograms of quantitative fluorescent poly-
merase chain reaction assays. The marker D15S533 shows two peaks (368 bp:
380 bp; maternal and paternal, respectively) of unequal fluorescent activity
from two different parental alleles in the fetal tissues with a dosage ratio of 1:2
(maternal:paternal) indicating a paternal origin of the duplication.
Table 1
Molecular results using polymorphic DNA markers specific for chromosome 15qa
Markers Father Mother
D15S526 273, 281 257, 277
D15S531 376, 376 360, 376
D15S533 352, 380 356, 368
a Alleles (base pair sizes) are listed below each individual.
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tion; secondary overgrowth which is due to humorally medi-
ated factors outside the skeletal system such as diabetic
macrosomia or congenital nesidioblastosis; and primary
overgrowth which is due to intrinsic cellular hyperplasia
[31,32]. Genetic considerations of primary overgrowth in
prenatal-onset overgrowth include trisomy or tetrasomy for
distal 15q or the chromosome 15q overgrowth syndrome [1],
proximal 4p deletion [33], deletion or microdeletion of 9q22.3
involving PTCH1, the gene responsible for Gorlin syndrome
(OMIM 109400) (autosomal dominant at 9q22.3) [34e37],
duplication of 4p16.3 [38], deletion of 22q13 [39,40], mosaic
tetrasomy 12p or Pallister-Killian syndrome (OMIM 601803)
(sporadic) [41e43], trisomy 12p [44], Beckwith-Wiedemann
syndrome (OMIM 130650) (imprinting defects, sporadic or
autosomal dominant) caused by loss of methylation at maternal
imprinting center 2 or differentially methylated region 2,
paternal uniparental disomy 11p15.5, mutations in CDKN1C,
gain of methylation at maternal imprinting center 1 or differ-
entially methylated region 1, 11p15.5 chromosome trans-
location/inversion or duplication, or unknown etiology [45,46],
Sotos syndrome (OMIM 117550) (sporadic or autosomal
dominant at 5q35) caused by NSD1 disease-causing mutations,
deletion or microdeletion of 5q35 [47,48], Weaver syndrome
(OMIM 277590) (sporadic and autosomal dominant at 5q35)
with some patients with mutations in the NSD1 gene [49],
Perlman syndrome (OMIM 267000) (autosomal recessive)
[50,51], Simpson-Golabi-Behmel syndrome (type I, OMIM
312870; X-linked recessive at Xq26.2) (type II, OMIM
300209; X-linked recessive at Xp22) caused by GPC3 muta-
tions, deletion, or microdeletion of Xq26.2 in type I; and
CXORF5mutations, deletion, or microdeletion of Xp22 in type
II [52e55], Costello syndrome (OMIM 218040) (autosomal
dominant at 11p15.5) caused by mutations in the HRAS gene
[56e60], Macrocephaly-capillary malformation syndrome
(OMIM 602501) (sporadic) [61e63], Nevo syndrome (OMIM
601451) (autosomal recessive) caused by mutations in PLOD1
gene [64], and PTEN hamartoma tumor syndrome such as
Bannayan-Riley-Ruvalcaba syndrome (OMIM 153480) (auto-
somal dominant at 10q23.31) [65,66] and Proteus syndrome
(OMIM 176920) (sporadic) [66,67], caused by mutations in the
PTEN gene.
In conclusion, the present case provides evidence for
prenatal overgrowth, craniosynostosis, and characteristic
facial dysmorphism in association with a duplication of
15q26.2/ q26.3 and a duplication of the IGF1R gene. Prenatal
diagnosis of fetal overgrowth should include a differential
diagnosis of the chromosome 15q overgrowth syndrome.Fetus Location
257, 281 15q26.1 (90,387,342e90,387,627)
360, 376 15q26.2 (94,521,647e94,521,997)
368, 380, 380 15q26.2 (98,082,884e98,083,244)
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